Clinical Trial Detail

NCT ID NCT04278781
Title AG-120 in People With IDH1 Mutant Chondrosarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

chondrosarcoma

Therapies

Ivosidenib

Age Groups: adult senior

Additional content available in CKB BOOST